Soi-Cheng Law

6PUBLICATIONS
48CO-AUTHORS
Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 10, 2026
Loss of systemic anti-viral immunity and LMP1-driven suppressive myeloid tumour niches converge to shape the immunobiology of Epstein-Barr virus-positive diffuse large B-cell lymphoma.

|Jun 20, 2025
T-cell dysregulation informs radiotherapy-immunotherapy response in B-cell lymphoma: results from a phase 1 trial.

Eliza A Hawkes, Jodie B Palmer, Richard Khor

|Aug 17, 2024
Intra-tumoral and peripheral blood TIGIT and PD-1 as immune biomarkers in nodular lymphocyte predominant Hodgkin lymphoma.

Jay Gunawardana, Soi C Law, Muhammed B Sabdia

|Dec 20, 2022
Inhibition of CD39 unleashes macrophage antibody-dependent cellular phagocytosis against B-cell lymphoma.

Mika Casey, Kane Segawa, Soi Cheng Law

|Jun 22, 2021
Intratumoral T cells have a differential impact on FDG-PET parameters in follicular lymphoma.

Karthik Nath, Soi-Cheng Law, Muhammed B Sabdia

|May 04, 2021
Successful treatment of Epstein-Barr virus-associated primary central nervous system lymphoma due to post-transplantation lymphoproliferative disorder, with ibrutinib and third-party Epstein-Barr virus-specific T cells.

Soi C Law, Thanh Hoang, Kacey O'Rourke

Pageof 1

Frequent Collaborators

6 joint publications

Maher K Gandhi

4 joint publications

Muhammed B Sabdia

4 joint publications

Colm Keane

3 joint publications

Joshua W D Tobin